` APH (Alliance Pharma PLC) vs FTSE All Share Index Comparison - Alpha Spread

APH
vs
FTSE All Share Index

Over the past 12 months, APH has significantly outperformed FTSE All Share Index, delivering a return of 65% compared to the FTSE All Share Index's 0% growth.

Stocks Performance
APH vs FTSE All Share Index

Loading
APH
FTSE All Share Index
Add Stock
www.alphaspread.com

Performance Gap
APH vs FTSE All Share Index

Loading
APH
FTSE All Share Index
Difference
www.alphaspread.com

Performance By Year
APH vs FTSE All Share Index

Loading
APH
FTSE All Share Index
Add Stock

Competitors Performance
Alliance Pharma PLC vs Peers

FTSE All Share Index
APH
LLY
JNJ
NOVO B
ROG
Add Stock

Alliance Pharma PLC
Glance View

Market Cap
349.7m GBX
Industry
Pharmaceuticals

Alliance Pharma Plc is a holding company, which engages in the acquisition, marketing, and distribution of healthcare and pharmaceutical products. The company is headquartered in Chippenham, Wiltshire and currently employs 255 full-time employees. The company went IPO on 2001-11-22. The firm is primarily engaged in the acquisition, marketing and distribution of healthcare and pharmaceutical products. The company is focused on two areas, which include Consumer Healthcare brands and Prescription Medicines. The Company’s Consumer Healthcare brands include Kelo-Cote, Nizoral, Amberen, MacuShield, Vamousse and Aloclair. Its Prescription Medicines include Hydromol, Flamma Franchise and Forceval. Its brands also include Ashton & Parsons and Anbesol. The Company’s products include Alliance Calcium Syrup, Amantadine hydrochloride, Aiweidi, Biodermatin, Biotaches, Buccastem M, Changmin, Decapional, Dermachronic, Dermacide, Dervida, Effadiane, Fazol, Gen-Ongles, Irenat, ISIB, Isocarboxazid, Jonctum, Kelo-Stretch, Lypsyl, Lefuzhi, Malunjunshe, MolluDab, Menadiol, Neostigmine and Nu-Seals. Its geographical area includes Europe, Middle East and Africa (EMEA), Asia Pacific and China (APAC) and Americas (AMER).

APH Intrinsic Value
106.32 GBX
Undervaluation 39%
Intrinsic Value
Price
A
Back to Top